Wed, Jul 23, 2014, 10:04 PM EDT - U.S. Markets closed


% | $
Click the to save as a favorite.

MultiCell Technologies, Inc. Message Board

  • gravity_master1 gravity_master1 Sep 17, 2013 10:16 AM Flag

    3 Big Biotech Buyouts of 2013

    The Chinese calendar says 2013 is the year of the snake, but the market says it's the year of biotech. Major biotechnology ETFs and indices have walloped the broader market by more than 25% since the beginning of the year.
    Acquisition No. 1: Onyx Pharmaceuticals In August, Amgen (NASDAQ: AMGN acquired Onyx Pharmaceuticals for $9.7 billion
    Acquisition No. 2: Elan In July, Perrigo (NYSE: PRGO ) bought Elan for $8.6 billion.
    Acquisition No. 3: Omthera In May, AstraZeneca (NYSE: AZN ) bought Omthera for $443 million.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
0.0007+0.0001(+16.67%)Jul 23 3:16 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Gilead Sciences Inc.
NasdaqGSWed, Jul 23, 2014 3:59 PM EDT